Filter
970
Filtered Results: 970
Text search:
National
Centre
for
Disease
Control
-
Delhi
Featured
Recommendations
89
New Publications
273
Language
Document type
No document type
522
Guidelines
187
Studies & Reports
143
Manuals
55
Strategic & Response Plan
29
Training Material
14
Fact sheets
9
Situation Updates
7
Infographics
3
Resource Platforms
1
Countries / Regions
India
281
Global
37
South–East Asia Region
32
Asia
24
Nepal
23
Brazil
17
Mozambique
11
Bangladesh
11
Kenya
10
Africa
8
Latin America and the Carribbean
8
Indonesia
8
Myanmar / Burma
8
Bolivia
7
Argentina
7
Ethiopia
7
Colombia
6
Paraguay
6
Angola
6
Thailand
5
Philippines
5
Guinea-Bissau
5
Tanzania
5
Rwanda
4
South Africa
4
Eastern Europe
4
Sri Lanka
4
Russia
4
Ecuador
4
Pakistan
4
Ukraine
3
Afghanistan
3
Zimbabwe
3
Cambodia
3
Vietnam
3
Bhutan
3
North Korea
2
Ghana
2
China
2
Chile
2
Iran
2
Laos
2
Senegal
2
Peru
2
Spain
2
Namibia
2
South Sudan
2
Somalia
2
Timor Leste/ East Timor
1
El Salvador
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Nigeria
1
Vanuatu
1
Qatar
1
USA
1
Haiti
1
Dominican Republic
1
Venezuela
1
Jordan
1
Congo, Democratic Republic of
1
West and Central Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Bosnia and Herzegovina
1
East and Southern Africa
1
Uganda
1
Papua New Guinea
1
Georgia
1
Libya
1
Zambia
1
Iraq
1
Liberia
1
Solomon Islands
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
412
Clinical Guidelines
93
Public Health
66
Women & Child Health
41
Key Resources
36
Pharmacy & Technologies
14
Capacity Building
7
Toolboxes
COVID-19
81
TB
78
NTDs
59
HIV
57
AMR
56
Mental Health
55
Caregiver
35
Rapid Response
31
Planetary Health
23
NCDs
18
Global Health Education
18
Disability
16
Pharmacy
16
Malaria
13
Natural Hazards
9
Refugee
7
Ebola & Marburg
6
Zika
6
Specific Hazards
5
Cholera
4
Health Financing Toolbox
3
Conflict
3
Social Ethics
2
Polio
2
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
Managing possible serious bacterial infection in young infants when referral is not feasible
recommended
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker. The guideline seeks to provide programmatic guida...
Instructional Manual for the care of pregnant and postpartum women in the context of the covid-19 pandemic
Este Manual de Recomendações para a Assistência à Gestante e Puérpera visa orientar o acesso e a horizontalidade da assistência durante a pandemia Covid-19, abordando as vias de transmis...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
The threat climate change poses to health, equity, and development has been rigorously documented. However, in an era marked by economic crisis, regional conflicts, natural disasters and growing disparities between rich and poor, the joint global actions required to address climate change have been ...
This guidance booklet on Menstrual Hygiene Management (MHM) is intended for adolescent girls and young women. Issues associated with menstruation are never discussed openly and the silence surrounding menstruation burdens young girls by keeping them ignorant of this biological function. Even after t...
The guidelines presented in this document are designed to provide a useful resource for healthcare professionals involved in clinical case management. They were developed taking into consideration services provided at different levels within the health system and resources available. These guideline...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
English version - This handbook sets out a the new paradigm for pharmacy practice. Its aim is to guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, which brings together practical tools and knowledge,...
Snakebite envenoming affects millions of people worldwide annually and is a significant source of mortality. Preventing and treating the problem is complex and requires collaboration among the fields of public health, medicine, ecology, and laboratory science. After being removed from the category A...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...
This Global Plan builds on the previous edition, which laid out priority actions for 2018-2022, informed by global commitments member states endorsed at the 2018 United Nations High-Level Meeting (UNHLM) on TB. The resource needs estimates from this Global Plan include resources needed for implement...
COVID - 19 and PREGNANCY
Management guidelines for SARS-CoV-2 infection
El Programa Nacional de Chagas ha definido la utilización de dos medicamentos para el tratamiento de la Enfermedad de Chagas Crónico Reciente Infantil (en niños de 9 meses a menor de 15 años); el benznidazol (BNZ) que será utilizado como medicamento de primera elección en todos los casos con d...
15 July 2021. This report describes the demographics, clinical presentation, clinical outcomes, and risk factors among people living with HIV (PLHIV) who have been hospitalized for suspected or confirmed COVID-19.
The specific objectives of the analysis were to:
describe the clinical char...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
The aim of the meeting was to broaden the network’s initiatives. Preliminary work involved integrating laboratory testing for skin NTDs other than Buruli ulcer, such as cutaneous leishmaniasis, mycetoma, leprosy and yaws, while extending the network’s reach to encompass additional laboratories.
Report on the symposium 26–28 May 2015, New Babylon Meeting Center, The Hague
